Crossroads of metabolism and CKD
- PMID: 30031444
- DOI: 10.1016/j.kint.2018.03.023
Crossroads of metabolism and CKD
Erratum in
-
Suzuki T, Abe T. Crossroads of metabolism and CKD. Kidney Int. 2018;94:242-243.Kidney Int. 2018 Oct;94(4):833. doi: 10.1016/j.kint.2018.07.011. Kidney Int. 2018. PMID: 30243325 No abstract available.
Abstract
Sensitive and useful biomarkers for predicting chronic kidney disease (CKD) and its prognosis are urgently needed. Using a nontargeted metabolomic approach, Hu et al. explored an established CKD cohort, Modification of Diet in Renal Disease, as well as a validation cohort, African American Study of Kidney Disease and Hypertension. They identified 3 serum metabolites (ribonate, fumarate, and allantoin) significantly associated with mortality in CKD even after statistical adjustment by multiple clinical covariates including glomerular filtration rate and urinary protein. Their finding develops a new aspect for diagnosing and predicting the prognosis of CKD.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Comment on
-
Serum metabolites are associated with all-cause mortality in chronic kidney disease.Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2. Kidney Int. 2018. PMID: 29871777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
